Leading the Way in Life Science Technologies

GEN Exclusives

More »
Small Molecules - Related Content
  • Insight & Intelligence™
  • More »
  • Culturing Primary Cells
    November 14, 2013

    A small molecule can reversibly proliferate primary RPE cells isolated from human donors.
  • Getting Around “Undruggable” Proto-Oncogenes
    October 30, 2013

    Investigators are finding ways to target proteins previously thought to be untargetable.
  • Binding MoA by DPI
    November 12, 2012

    Researchers investigate the application of dual-polarization interferometry (DPI) as a method for the real-time characterization of low molecular weight ligands.
  • New Luciferins
    July 30, 2012

    Researchers describe a rapid method to synthesize D-luciferin along with a novel set of electronically modified analogues.
  • A SPA for PMTs
    July 23, 2012

    Researchers propose a SPA strategy that can be successfully implemented to identify novel and specific inhibitors of PMTs.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »